Stock Repurchase Plan Declared by Doximity (NASDAQ:DOCS) Board

Doximity (NASDAQ:DOCS) declared that its Board of Directors has initiated a stock repurchase program on Thursday, February 5th, RTT News reports. The company plans to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 8% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DOCS shares. Royal Bank Of Canada started coverage on Doximity in a research report on Thursday, January 8th. They set an “outperform” rating and a $59.00 price objective for the company. Barclays initiated coverage on shares of Doximity in a research report on Monday, December 8th. They issued an “overweight” rating and a $63.00 price target on the stock. Truist Financial set a $62.00 target price on shares of Doximity in a research report on Thursday, January 8th. Canaccord Genuity Group set a $48.00 target price on Doximity in a research report on Thursday, January 8th. Finally, Mizuho set a $45.00 price objective on shares of Doximity in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Doximity presently has an average rating of “Moderate Buy” and an average price target of $64.95.

Doximity Trading Down 5.5%

DOCS stock traded down $1.95 on Thursday, hitting $33.30. The company had a trading volume of 9,431,108 shares, compared to its average volume of 3,212,373. The stock has a market cap of $6.27 billion, a price-to-earnings ratio of 33.30, a P/E/G ratio of 4.10 and a beta of 1.39. The stock’s 50-day simple moving average is $43.16 and its 200 day simple moving average is $56.92. Doximity has a 12-month low of $32.66 and a 12-month high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 EPS. Research analysts forecast that Doximity will post 0.99 earnings per share for the current year.

Key Stories Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Q3 results beat consensus on both EPS and revenue: $0.46 EPS (vs. ~$0.45) and roughly $185.1M revenue (up ~10% YoY), with strong profitability (net margin ~36.6%). This shows the core business remains profitable and growing. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Positive Sentiment: User engagement and product traction remain healthy: the company highlighted record engagement (over 1M quarterly active prescribers) and a sequential jump in workflow-product users, indicating demand for its clinical workflow and professional network offerings. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Neutral Sentiment: Analyst write-ups dig into metric details (growth rates, engagement vs. estimates) that can guide revisions; they confirm the quarter beat but focus investor attention on forward trends. Here’s What Key Metrics Tell Us About Doximity (DOCS) Q3 Earnings
• Negative Sentiment: Management’s forward guidance disappointed: Q4 revenue was guided to ~$143.0–$144.0M vs. consensus near $150.2M, and FY26 revenue guidance (~$642.5–$643.5M) was marginally below Street estimates — the guidance miss is the main driver of the sell-off. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Negative Sentiment: Market reaction was sharp: shares plunged after-hours and trading volume spiked as investors sold into the weaker guidance despite the quarter’s beats. Momentum and multiple compression are likely contributors to today’s downside. Doximity Stock Is Collapsing After Hours: Here’s Why

Doximity Company Profile

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.